2011-08-23
Response to letter regarding article, "intracoronary versus intravenous administration of abciximab in patients with st-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: The comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of st-segment elevation myocardial infarction
Publication
Publication
Circulation (Baltimore) , Volume 124 - Issue 8
| Additional Metadata | |
|---|---|
| doi.org/10.1161/CIRCULATIONAHA.111.032961, hdl.handle.net/1765/33324 | |
| Circulation (Baltimore) | |
| Organisation | Erasmus MC: University Medical Center Rotterdam |
|
Gu, Y., Kampinga, M., Wieringa, W., Fokkema, M., Hillege, H., van den Heuvel, A., Tan, E.-S., Pundziute, G., van der Werf, R., Guyomi, S. H., van der Horst, I., de Smet, B., Nijsten, M.& Zijlstra, F. (2011). Response to letter regarding article, "intracoronary versus intravenous administration of abciximab in patients with st-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: The comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of st-segment elevation myocardial infarction. Circulation (Baltimore), 124(8).https://doi.org/10.1161/CIRCULATIONAHA.111.032961 |
|